Global Biomarker Testing Services Market Size study & Forecast, by Product (Biomarker Assay Development, Flow Cytometry and Others) by End User (Pharmaceutical and biotechnology companies, Research Institutes and CRO) and Regional Analysis, 2022-2029
Global Biomarker Testing Services Market is valued at approximately USD 759.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029. Biomarker testing services give a powerful approach to measuring a biological process and act as an indicator in normal as well as pathological conditions in response to pharmacological intervention. To research human diseases, doctors have used biomarker analysis in blood or other body fluids at the DNA or protein level for many years. Clinical illnesses such as cancer, immunological responses, genetic disorders, and cardiovascular diseases are among the conditions that doctors frequently use biomarker services to identify and treat. The Biomarker Testing Services market is expanding because of factors such as increasing demand for biomarker testing for cancer detection and increasing R&D activities.
New biomarkers are being discovered because of research and development. For instance, sTNFR2 was identified as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma in 2020. Similar to this, in 2018 the FDA approved the Plasmodium 18S rRNA/rDNA biomarker for the treatment of malaria. Due to these discoveries and technical improvements, the market is predicted to grow profitably during the forecast period. The successful launch of this product may provide patients with an alternative option. Furthermore, the growing demand for biomarkers in clinical studies and the growing burden of chronic and infectious diseases supporting demand for biomarker testing is creating lucrative growth in the market. However, the high cost of biomarker testing services and high capital investments and lengthy timelines for biomarker development stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Biomarker Testing Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market share owing to factors such as the rising presence of key market players, increase in laboratory diagnostic testing, and prevalence of lifestyle diseases. In 2020, the CDC projects that there may be about 37.3 million diabetes in the country, including 28.7 million cases that have been diagnosed and 8.5 million that have not. A growing geriatric and target population, an increase in the number of collaborations for biosimilar development, the geographic expansion of key players, and active participation by government and nonprofit organisations in the market space are just a few of the factors driving Asia Pacific's expected significant growth during the forecast period.
Major market player included in this report are:
Bio Agilytix Labs
Eurofins Scientific
SGS SA
Charles River Laboratories
Labcorp Drug Development
Thermo Fisher Scientific Inc. (PPD, Inc.)
ICON Plc
IQVIA
Syneos Health
Intertek Group Plc
Recent Developments in the Market:
In April2021, Amgen announced the launch of Biomarker AssistTM, a programme to make biomarker testing more accessible to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker AssistTM.
In February 2022, oncodna introduced the launch of the oncodeep kit. a complete workflow solution is provided by the kit, permitting laboratories with ngs capabilities to perform comprehensive biomarker testing, provide powerful data analysis, and support oncologists in the most effective and personalized treatments for their cancer patients. For the quick analysis and reporting of a patient's tumor molecular profile, the offer will come in combination with oncodna's data analysis and clinical interpretation tools.
Global Biomarker Testing Services Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Biomarker Assay Development
Flow Cytometry
Others
By End User:
Pharmaceutical and biotechnology companies
Research Institutes
CRO
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
New biomarkers are being discovered because of research and development. For instance, sTNFR2 was identified as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma in 2020. Similar to this, in 2018 the FDA approved the Plasmodium 18S rRNA/rDNA biomarker for the treatment of malaria. Due to these discoveries and technical improvements, the market is predicted to grow profitably during the forecast period. The successful launch of this product may provide patients with an alternative option. Furthermore, the growing demand for biomarkers in clinical studies and the growing burden of chronic and infectious diseases supporting demand for biomarker testing is creating lucrative growth in the market. However, the high cost of biomarker testing services and high capital investments and lengthy timelines for biomarker development stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Biomarker Testing Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market share owing to factors such as the rising presence of key market players, increase in laboratory diagnostic testing, and prevalence of lifestyle diseases. In 2020, the CDC projects that there may be about 37.3 million diabetes in the country, including 28.7 million cases that have been diagnosed and 8.5 million that have not. A growing geriatric and target population, an increase in the number of collaborations for biosimilar development, the geographic expansion of key players, and active participation by government and nonprofit organisations in the market space are just a few of the factors driving Asia Pacific's expected significant growth during the forecast period.
Major market player included in this report are:
Bio Agilytix Labs
Eurofins Scientific
SGS SA
Charles River Laboratories
Labcorp Drug Development
Thermo Fisher Scientific Inc. (PPD, Inc.)
ICON Plc
IQVIA
Syneos Health
Intertek Group Plc
Recent Developments in the Market:
In April2021, Amgen announced the launch of Biomarker AssistTM, a programme to make biomarker testing more accessible to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker AssistTM.
In February 2022, oncodna introduced the launch of the oncodeep kit. a complete workflow solution is provided by the kit, permitting laboratories with ngs capabilities to perform comprehensive biomarker testing, provide powerful data analysis, and support oncologists in the most effective and personalized treatments for their cancer patients. For the quick analysis and reporting of a patient's tumor molecular profile, the offer will come in combination with oncodna's data analysis and clinical interpretation tools.
Global Biomarker Testing Services Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Biomarker Assay Development
Flow Cytometry
Others
By End User:
Pharmaceutical and biotechnology companies
Research Institutes
CRO
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Biomarker Testing Services Market, by Region, 2019-2029 (USD Million)
1.2.2. Biomarker Testing Services Market, by Product, 2019-2029 (USD Million)
1.2.3. Biomarker Testing Services Market, by End User, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BIOMARKER TESTING SERVICES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BIOMARKER TESTING SERVICES MARKET DYNAMICS
3.1. Biomarker Testing Services Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for biomarker testing for cancer detection
3.1.1.2. Increasing R&D activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Biomarker Testing Services
3.1.2.2. High capital investments and lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Growing burden of chronic and infectious diseases supporting demand for biomarker testing
CHAPTER 4. GLOBAL BIOMARKER TESTING SERVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL BIOMARKER TESTING SERVICES MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Biomarker Testing Services Market by Product, Performance - Potential Analysis
6.3. Global Biomarker Testing Services Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Biomarker Testing Services Market, Sub Segment Analysis
6.4.1. Biomarker Assay Development
6.4.2. Flow Cytometry
6.4.3. Others
CHAPTER 7. GLOBAL BIOMARKER TESTING SERVICES MARKET, BY END USER
7.1. Market Snapshot
7.2. Global Biomarker Testing Services Market by End User, Performance - Potential Analysis
7.3. Global Biomarker Testing Services Market Estimates & Forecasts by End User 2019-2029 (USD Million)
7.4. Biomarker Testing Services Market, Sub Segment Analysis
7.4.1. Pharmaceutical and biotechnology companies
7.4.2. Research Institutes
7.4.3. CRO
CHAPTER 8. GLOBAL BIOMARKER TESTING SERVICES MARKET, REGIONAL ANALYSIS
8.1. Biomarker Testing Services Market, Regional Market Snapshot
8.2. North America Biomarker Testing Services Market
8.2.1. U.S. Biomarker Testing Services Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Biomarker Testing Services Market
8.3. Europe Biomarker Testing Services Market Snapshot
8.3.1. U.K. Biomarker Testing Services Market
8.3.2. Germany Biomarker Testing Services Market
8.3.3. France Biomarker Testing Services Market
8.3.4. Spain Biomarker Testing Services Market
8.3.5. Italy Biomarker Testing Services Market
8.3.6. Rest of Europe Biomarker Testing Services Market
8.4. Asia-Pacific Biomarker Testing Services Market Snapshot
8.4.1. China Biomarker Testing Services Market
8.4.2. India Biomarker Testing Services Market
8.4.3. Japan Biomarker Testing Services Market
8.4.4. Australia Biomarker Testing Services Market
8.4.5. South Korea Biomarker Testing Services Market
8.4.6. Rest of Asia Pacific Biomarker Testing Services Market
8.5. Latin America Biomarker Testing Services Market Snapshot
8.5.1. Brazil Biomarker Testing Services Market
8.5.2. Mexico Biomarker Testing Services Market
8.6. Rest of The World Biomarker Testing Services Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bio Agilytix Labs
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Euro fins Scientific
9.2.3. SGS SA
9.2.4. Charles River Laboratories
9.2.5. Labcorp Drug Development
9.2.6. Thermo Fisher Scientific Inc. (PPD, Inc.)
9.2.7. ICON Plc
9.2.8. IQVIA
9.2.9. Syneos Health
9.2.10. Intertek Group Plc
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Biomarker Testing Services Market, by Region, 2019-2029 (USD Million)
1.2.2. Biomarker Testing Services Market, by Product, 2019-2029 (USD Million)
1.2.3. Biomarker Testing Services Market, by End User, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BIOMARKER TESTING SERVICES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BIOMARKER TESTING SERVICES MARKET DYNAMICS
3.1. Biomarker Testing Services Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for biomarker testing for cancer detection
3.1.1.2. Increasing R&D activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Biomarker Testing Services
3.1.2.2. High capital investments and lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Growing burden of chronic and infectious diseases supporting demand for biomarker testing
CHAPTER 4. GLOBAL BIOMARKER TESTING SERVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL BIOMARKER TESTING SERVICES MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Biomarker Testing Services Market by Product, Performance - Potential Analysis
6.3. Global Biomarker Testing Services Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Biomarker Testing Services Market, Sub Segment Analysis
6.4.1. Biomarker Assay Development
6.4.2. Flow Cytometry
6.4.3. Others
CHAPTER 7. GLOBAL BIOMARKER TESTING SERVICES MARKET, BY END USER
7.1. Market Snapshot
7.2. Global Biomarker Testing Services Market by End User, Performance - Potential Analysis
7.3. Global Biomarker Testing Services Market Estimates & Forecasts by End User 2019-2029 (USD Million)
7.4. Biomarker Testing Services Market, Sub Segment Analysis
7.4.1. Pharmaceutical and biotechnology companies
7.4.2. Research Institutes
7.4.3. CRO
CHAPTER 8. GLOBAL BIOMARKER TESTING SERVICES MARKET, REGIONAL ANALYSIS
8.1. Biomarker Testing Services Market, Regional Market Snapshot
8.2. North America Biomarker Testing Services Market
8.2.1. U.S. Biomarker Testing Services Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Biomarker Testing Services Market
8.3. Europe Biomarker Testing Services Market Snapshot
8.3.1. U.K. Biomarker Testing Services Market
8.3.2. Germany Biomarker Testing Services Market
8.3.3. France Biomarker Testing Services Market
8.3.4. Spain Biomarker Testing Services Market
8.3.5. Italy Biomarker Testing Services Market
8.3.6. Rest of Europe Biomarker Testing Services Market
8.4. Asia-Pacific Biomarker Testing Services Market Snapshot
8.4.1. China Biomarker Testing Services Market
8.4.2. India Biomarker Testing Services Market
8.4.3. Japan Biomarker Testing Services Market
8.4.4. Australia Biomarker Testing Services Market
8.4.5. South Korea Biomarker Testing Services Market
8.4.6. Rest of Asia Pacific Biomarker Testing Services Market
8.5. Latin America Biomarker Testing Services Market Snapshot
8.5.1. Brazil Biomarker Testing Services Market
8.5.2. Mexico Biomarker Testing Services Market
8.6. Rest of The World Biomarker Testing Services Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bio Agilytix Labs
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Euro fins Scientific
9.2.3. SGS SA
9.2.4. Charles River Laboratories
9.2.5. Labcorp Drug Development
9.2.6. Thermo Fisher Scientific Inc. (PPD, Inc.)
9.2.7. ICON Plc
9.2.8. IQVIA
9.2.9. Syneos Health
9.2.10. Intertek Group Plc
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Biomarker Testing Services Market, report scope
TABLE 2. Global Biomarker Testing Services Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Biomarker Testing Services Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 4. Global Biomarker Testing Services Market estimates & forecasts by End User 2019-2029 (USD Million)
TABLE 5. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Biomarker Testing Services Market
TABLE 70. List of primary sources, used in the study of global Biomarker Testing Services Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Biomarker Testing Services Market, report scope
TABLE 2. Global Biomarker Testing Services Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Biomarker Testing Services Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 4. Global Biomarker Testing Services Market estimates & forecasts by End User 2019-2029 (USD Million)
TABLE 5. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Biomarker Testing Services Market
TABLE 70. List of primary sources, used in the study of global Biomarker Testing Services Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Biomarker Testing Services Market, research methodology
FIG 2. Global Biomarker Testing Services Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biomarker Testing Services Market, key trends 2021
FIG 5. Global Biomarker Testing Services Market, growth prospects 2022-2029
FIG 6. Global Biomarker Testing Services Market, porters 5 force model
FIG 7. Global Biomarker Testing Services Market, pest analysis
FIG 8. Global Biomarker Testing Services Market, value chain analysis
FIG 9. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Biomarker Testing Services Market, regional snapshot 2019 & 2029
FIG 15. North America Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 16. Europe Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 18. Latin America Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 19. Global Biomarker Testing Services Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Biomarker Testing Services Market, research methodology
FIG 2. Global Biomarker Testing Services Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biomarker Testing Services Market, key trends 2021
FIG 5. Global Biomarker Testing Services Market, growth prospects 2022-2029
FIG 6. Global Biomarker Testing Services Market, porters 5 force model
FIG 7. Global Biomarker Testing Services Market, pest analysis
FIG 8. Global Biomarker Testing Services Market, value chain analysis
FIG 9. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Biomarker Testing Services Market, regional snapshot 2019 & 2029
FIG 15. North America Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 16. Europe Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 18. Latin America Biomarker Testing Services Market 2019 & 2029 (USD Million)
FIG 19. Global Biomarker Testing Services Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
